INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MEYER AND TIMMERMAN

被引：1
|
作者：
Brown, Martin [1 ]
Lao, Billy [1 ]
Diehn, Maximillian [1 ]
Carlson, David [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 79卷 / 05期
关键词：
D O I：
10.1016/j.ijrobp.2010.11.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1600 / 1600
页数：1
相关论文
共 50 条
  • [41] Evaluating dose coverage and conformity in stereotactic ablative body radiotherapy (SABR) plans
    O'Keeffe, Serena
    Fleming, Cathy
    Vintro, Luis Leon
    Mcclean, Brendan
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 118
  • [42] TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MPLC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Griffioen, Gwendolyn H.
    Lagerwaard, Frank
    Haasbeek, Cornelis J.
    Smit, Egbert
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S839 - S839
  • [43] Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic Gynecologic Malignancies: A Single Institution Experience
    Cuttino, L. W.
    Evans, J. E.
    Snyder, W. J.
    Ford, T. C.
    Egloff, S. Arnold
    Boardman, C. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E266 - E266
  • [44] Stereotactic Ablative Radiotherapy (SABR) For Oligometastases: Risk Stratification Using Positional Uncertainty
    Zhang, T.
    Clark, H.
    Thomas, S.
    Olson, R. A.
    Ma, R.
    Schellenberg, D.
    Tyldesley, S.
    Palma, D. A.
    Liu, M. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E180 - E181
  • [45] The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
    Finkelstein, Steven Eric
    Timmerman, Robert
    McBride, WilliamH.
    Schaue, Doerthe
    Hoffe, Sarah E.
    Mantz, Constantine A.
    Wilson, George D.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [46] Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity
    Murray, Louise
    Karakaya, Ebru
    Hinsley, Samantha
    Naisbitt, Mitchell
    Lilley, John
    Snee, Michael
    Clarke, Katy
    Musunuru, Hima B.
    Ramasamy, Satiavani
    Turner, Rob
    Franks, Kevin
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1058):
  • [47] Stereotactic ablative Radiotherapy (SABR) for Adrenal Metastases: high Efficacy with low Toxicity
    Koos, V
    Kretschmer, M.
    Dahle, J.
    Sabatino, M.
    Feine, D.
    Wuerschmidt, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S43 - S44
  • [48] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [49] Implementation of Stereotactic Ablative Body Radiotherapy (SABR) for Spinal Oligometatases: Initial Experiences
    Smyth, M.
    Williams, M.
    Jones, S.
    Woodley, O.
    Bryant, A.
    Matthams, C.
    Maloney, H.
    Millin, T.
    Palaniappan, N.
    Rackley, T.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E57 - E57
  • [50] The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence
    Nicosia, L.
    Mazzola, R.
    Alongi, E.
    CLINICAL ONCOLOGY, 2022, 34 (07) : E320 - E321
12345